JP2019522626A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019522626A5 JP2019522626A5 JP2018557105A JP2018557105A JP2019522626A5 JP 2019522626 A5 JP2019522626 A5 JP 2019522626A5 JP 2018557105 A JP2018557105 A JP 2018557105A JP 2018557105 A JP2018557105 A JP 2018557105A JP 2019522626 A5 JP2019522626 A5 JP 2019522626A5
- Authority
- JP
- Japan
- Prior art keywords
- hiv
- protein
- modified
- vaccine composition
- seq
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662330604P | 2016-05-02 | 2016-05-02 | |
| US62/330,604 | 2016-05-02 | ||
| PCT/US2017/030375 WO2017192434A1 (en) | 2016-05-02 | 2017-05-01 | Compositions and methods related to hiv-1 immunogens |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019522626A JP2019522626A (ja) | 2019-08-15 |
| JP2019522626A5 true JP2019522626A5 (enExample) | 2020-02-06 |
| JP7046832B2 JP7046832B2 (ja) | 2022-04-04 |
Family
ID=60203504
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018557105A Active JP7046832B2 (ja) | 2016-05-02 | 2017-05-01 | Ｈｉｖ－１免疫原に関連した組成物および方法 |
Country Status (12)
| Country | Link |
|---|---|
| US (5) | US10647748B2 (enExample) |
| EP (1) | EP3452494A4 (enExample) |
| JP (1) | JP7046832B2 (enExample) |
| CN (1) | CN109153704A (enExample) |
| AU (2) | AU2017259275C1 (enExample) |
| CA (1) | CA3022826A1 (enExample) |
| EA (1) | EA201892233A1 (enExample) |
| IL (2) | IL299962A (enExample) |
| MX (1) | MX2018013455A (enExample) |
| SG (1) | SG11201809387QA (enExample) |
| WO (1) | WO2017192434A1 (enExample) |
| ZA (1) | ZA201807216B (enExample) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3050914A1 (en) * | 2017-01-27 | 2018-08-02 | The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. | Vaccine compositions of herpesvirus envelope protein combinations to induce immune response |
| AU2019285048B2 (en) * | 2018-06-13 | 2023-06-08 | The Scripps Research Institute | Nanoparticle vaccines with novel structural components |
| WO2020117760A1 (en) * | 2018-12-03 | 2020-06-11 | Duke University | Purification method for recombinant proteins and nanoparticles |
| EP4003513A4 (en) * | 2019-07-26 | 2023-08-30 | The Scripps Research Institute | MODIFIED HCV E2 IMMUNOGENS AND ASSOCIATED VACCINE COMPOSITIONS |
| US20230134571A1 (en) * | 2019-10-29 | 2023-05-04 | International Aids Vaccine Initiative | Engineered antibodies to hiv env |
| CA3159907A1 (en) * | 2019-11-07 | 2021-05-14 | Janssen Vaccines & Prevention B.V. | Protein purification |
| CN111647078B (zh) * | 2020-06-22 | 2022-04-26 | 中国医学科学院医学生物学研究所 | 一种抗hiv的单克隆抗体及其制备方法和应用 |
| US10906944B2 (en) | 2020-06-29 | 2021-02-02 | The Scripps Research Institute | Stabilized coronavirus spike (S) protein immunogens and related vaccines |
| WO2022100703A1 (zh) * | 2020-11-12 | 2022-05-19 | 厦门大学 | 经改造的人免疫缺陷病毒膜蛋白及其应用 |
| CN116769053B (zh) * | 2023-05-26 | 2023-12-15 | 华中农业大学 | 重组AaLS-BPP融合肽、制备方法及应用 |
| CN121293297B (zh) * | 2025-12-04 | 2026-05-05 | 广州千扬生物医药技术有限公司 | 一种hiv纳米颗粒疫苗 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1135181A (zh) | 1993-09-14 | 1996-11-06 | Cytel有限公司 | 使用泛dr结合肽改变免疫应答 |
| US7550143B2 (en) | 2005-04-06 | 2009-06-23 | Ibc Pharmaceuticals, Inc. | Methods for generating stably linked complexes composed of homodimers, homotetramers or dimers of dimers and uses |
| EP2073840A4 (en) * | 2006-10-23 | 2010-10-27 | Progenics Pharm Inc | MODIFIED GP140-HOLL-POLYPEPTIDES OF HIV-1 ISOLATES, COMPOSITIONS, STABILIZED TRIMERS, COMPLEXES, AND ITS USES |
| CA2705373A1 (en) | 2007-11-12 | 2009-08-20 | The Henry M. Jackson Foundation For The Advancement Of Military Medicine , Inc. | Hiv-1 envelope glycoprotein oligomer and methods of use |
| WO2009109428A2 (en) | 2008-02-01 | 2009-09-11 | Alpha-O Peptides Ag | Self-assembling peptide nanoparticles useful as vaccines |
| EP2765138B1 (en) | 2012-11-05 | 2018-01-10 | International Aids Vaccine Initiative | HIV-1 envelope glycoprotein |
| WO2014107744A1 (en) | 2013-01-07 | 2014-07-10 | Beth Israel Deaconess Medical Center, Inc. | Stabilized human immunodeficiency virus (hiv) envelope (env) trimer vaccines and methods of using the same |
| US10400015B2 (en) | 2014-09-04 | 2019-09-03 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Recombinant HIV-1 envelope proteins and their use |
| WO2016138525A1 (en) | 2015-02-27 | 2016-09-01 | University Of Washington | Polypeptide assemblies and methods for the production thereof |
| JP7178344B2 (ja) * | 2016-09-15 | 2022-11-25 | ヤンセン ファッシンズ アンド プリベンション ベーフェー | 三量体安定化ｈｉｖエンベロープタンパク質変異 |
-
2017
- 2017-05-01 CN CN201780027483.6A patent/CN109153704A/zh active Pending
- 2017-05-01 SG SG11201809387QA patent/SG11201809387QA/en unknown
- 2017-05-01 EP EP17793064.1A patent/EP3452494A4/en active Pending
- 2017-05-01 CA CA3022826A patent/CA3022826A1/en active Pending
- 2017-05-01 JP JP2018557105A patent/JP7046832B2/ja active Active
- 2017-05-01 WO PCT/US2017/030375 patent/WO2017192434A1/en not_active Ceased
- 2017-05-01 MX MX2018013455A patent/MX2018013455A/es unknown
- 2017-05-01 AU AU2017259275A patent/AU2017259275C1/en active Active
- 2017-05-01 EA EA201892233A patent/EA201892233A1/ru unknown
- 2017-05-01 IL IL299962A patent/IL299962A/en unknown
-
2018
- 2018-10-24 IL IL262582A patent/IL262582B2/en unknown
- 2018-10-29 ZA ZA2018/07216A patent/ZA201807216B/en unknown
- 2018-10-31 US US16/176,200 patent/US10647748B2/en active Active
-
2020
- 2020-02-03 US US16/780,495 patent/US11236134B2/en active Active
-
2021
- 2021-08-25 AU AU2021221582A patent/AU2021221582B2/en active Active
- 2021-12-16 US US17/553,070 patent/US11767347B2/en active Active
-
2023
- 2023-08-15 US US18/449,739 patent/US20240083954A1/en not_active Abandoned
-
2024
- 2024-08-28 US US18/817,389 patent/US20250122247A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7250878B2 (ja) | 新規多価ナノ粒子に基づくワクチン | |
| AU2019285048B2 (en) | Nanoparticle vaccines with novel structural components | |
| JP2021527077A5 (enExample) | ||
| JP2021502807A5 (enExample) | ||
| EP3474893A1 (en) | Self-assembling insect ferritin nanoparticles for display of co-assembled trimeric antigens | |
| US10906943B2 (en) | Virus-like particles with high-density coating for inducing the expression of antibodies | |
| IL274130B2 (en) | Novel scaffolded hiv-1 vaccine immunogens | |
| US20190016760A1 (en) | Multimerization of Recombinant Protein by Fusion to a Sequence from Lamprey | |
| JP2016520534A5 (enExample) | ||
| CN107344969B (zh) | 一种纳米流感疫苗及构建方法和应用 | |
| Yong et al. | Development of virus‐like particles‐based vaccines against coronaviruses | |
| HK1245809A1 (en) | Multimerization of recombinant protein by fusion to a sequence from lamprey | |
| JP2020509770A5 (enExample) | ||
| US10899801B2 (en) | Production of soluble HIV envelope trimers in planta | |
| EP2748186A1 (en) | Method for removing immunosuppresive properties of hiv envelope glycoproteins | |
| US20240189407A1 (en) | Modified virus-like particles of bacteriophage ap205 | |
| US9566329B2 (en) | Live, attenuated rubella vector to express vaccine antigens | |
| CN111163801A (zh) | 用于流感病毒的基于乙型肝炎纳米颗粒的疫苗 | |
| TH87137A (th) | องค์ประกอบวัคซีน |